Mankind Pharma Ltd logo

Mankind Pharma Ltd (MANKIND)


Get free price alerts. Set up your Free investment account to get Live Prices. >
News and Events

Overview of Mankind Pharma Ltd

Key events for Mankind Pharma Ltd

  • Mankind Pharma Commences Commercial Operations at New Plant in Rajasthan - 25 Sep, 2023

    Mankind Pharma Ltd has started commercial operations for pharmaceutical formulations at its new plant in Udaipur, Rajasthan.

  • Mankind Pharma's IPO Sees Stock Soar 32% - 22 Sep, 2023

    Mankind Pharma, India's leading condom maker with a 33% market share, conducted a $520 million IPO in May and saw its stock soar 32% on debut, valuing the company at $7 billion.

  • Mankind Pharma Soars on Market Debut After Successful IPO - 21 Sep, 2023

    Mankind Pharma Ltd's successful $520 million IPO in May led to a 32% surge in stock prices on its market debut, resulting in a valuation of $7 billion.

  • Mankind Pharma IPO to Open Next Week - 15 Sep, 2023

    Mankind Pharma Ltd is set to launch its initial public offering (IPO) next week. Details on the price band and grey market premium are yet to be announced.

  • Mankind Pharma Reports Highest Growth in August - 13 Sep, 2023

    According to the All India Organisation of Chemists and Druggists, Mankind Pharma Ltd. reported the highest growth in August at 10%.

  • Mankind Pharma Among Top Stocks to Watch Today - 04 Sep, 2023

    No specific news related to Mankind Pharma Ltd. However, the company is among the top stocks to watch today.

  • Lock-In Release for Majority Stake in Mankind Pharma - 28 Aug, 2023

    Around 280 million shares, or 70% of Mankind Pharma's stake, will be released from lock-in on November 06. The company had the largest IPO in the pharma sector earlier this year.

  • Mankind Pharma to Incorporate Wholly Owned Subsidiary - 25 Aug, 2023

    Mankind Pharma Ltd's board has approved the incorporation of a wholly owned subsidiary, Mankind Medicare, with an authorized capital of Rs 5 crore. The subsidiary will manufacture pharmaceutical dosage forms and consumer healthcare products.

  • Investor Impressed with Mankind Pharma - 24 Aug, 2023

    An investor expresses interest in finding the right entry point for Mankind Pharma Ltd.

  • Mankind Pharma Outperforms Indian Pharma Market - 22 Aug, 2023

    Mankind Pharma, with 97% of revenue from India alone, consistently outperformed the sales growth of the overall Indian pharma market. The management is betting on chronic therapies to drive next leg of growth.

  • Mankind Pharma Stock Rises Despite Market Share Loss - 14 Aug, 2023

    Despite losing maximum market share in the Indian pharma market over the past six months, Mankind Pharma's stock rose to Rs 1,834.4 apiece.

  • Mankind Pharma Achieves 20 SMA of Rs 1837.4 - 11 Aug, 2023

    On August 10, Mankind Pharma achieved a 20-day Simple Moving Average (SMA) of Rs 1837.4 and closed at Rs 1841.6 on the same day.

  • Mankind Pharma Shares Rise Despite Recent Losses - 09 Aug, 2023

    Mankind Pharma Ltd's shares rose by 0.59% following strong Q1 results, despite a recent loss of 2.27%. The company's RSI has dropped to 49.24.

  • Mankind Pharma's Stock Continues Uptrend - 04 Aug, 2023

    Mankind Pharma Ltd's stock continues to rise with the company's recent IPO rallying 61%, and the RSI rising above 60 indicating a potential continuation of the uptrend.

  • Mankind Pharma Reports Strong Q1FY24 Results - 03 Aug, 2023

    Mankind Pharma Ltd reported a sharp increase in Q1FY24 net profit and revenue, driven by strong domestic sales and industry-beating growth from its pharma segment.

  • Mankind Pharma Reports Strong Q1 Results - 02 Aug, 2023

    Mankind Pharma's Q1FY24 results show strong double-digit growth in sales and profitability, with pharma segment outperforming IPM by 1.5x. Shares close 1.81% lower.

  • Mankind Pharma to Announce Q1 Results - 01 Aug, 2023

    Mankind Pharma Ltd will be in focus as it is set to announce its June quarter results.

  • Mankind Pharma Upgraded to Large Caps; Restructures Portfolio - 31 Jul, 2023

    Mankind Pharma Ltd has been upgraded from mid to large caps and has restructured its portfolio in favor of mid-cap stocks.

  • Mankind Pharma Discontinues Cough Syrup and Has Biggest IPO This Year - 20 Jul, 2023

    Mankind Pharma discontinues its cough syrup Tedykoff since February. The company also had the biggest public issue this year with an IPO size of Rs 4,326 crore.

  • Mankind Pharma's Strong Debut on the Stock Market - 19 Jul, 2023

    Mankind Pharma had a strong debut on the stock market, listing at a premium of 15% over its issue price. It was the only public offer in 2023 with an issue size of over Rs 1,000 crore.

Analyst Rating

based on 10 analysts


Based on 10 analysts offering long term price targets for Mankind Pharma Ltd. An average target of ₹1837.8

Source: S&P Global Market Intelligence

Mankind Pharma Ltd Performance

  • ₹1721.55
    downward going graph



    Day's Volatility:2.20%



    downward going graph
  • ₹1242
    downward going graph



    52 Weeks Volatility:40.57%



    downward going graph
1 Month Return-1.2 %
3 Month Return2.87 %
1 Year Return23.17 %
Previous Close₹1,751.80
Market Cap₹70,175.08Cr

Mankind Pharma Ltd Company Information

Mankind Pharma Ltd. was established in 1991 as a Private Limited Company. In 2005 it was converted to a Public Limited Company and the name changed to Mankind Pharma Limited. The Company is engaged in the development, manufacturing and marketing of a range of pharmaceuticals and consumer healthcare products, and is active in acute and chronic therapeutic areas such as anti-infectives, cardiovascular and gastrointestinal treatments, antidiabetic and neuro/CNS medicines, vitamins, minerals and nutrients. In 2004, they entered the chronic pharmaceutical segment, and have added further products over the years, including ophthalmic products, consumer healthcare products, animal healthcare products and specialty therapeutic divisions. They operate 23 manufacturing facilities across India and had 2181 manufacturing personnel as of March 31, 2021. It is now planning to raise capital through the public offering of 40058844 equity shares, with a total installed capacity of 40.77 billion units across a range of products.

Share Price: ₹1742.55 per share as on 25 Sep, 2023 04:01 PM
Market Capitalisation: ₹70,175.08Cr as of today
Revenue: ₹2,102.95Cr as on March 2023 (Q1 23)
Net Profit: ₹285.44Cr as on March 2023 (Q1 23)
Listing date: 09 May, 2023
OrganisationMankind Pharma Ltd
HeadquartersNew Delhi
E-voting on sharesClick here to vote

Fundamentals of Mankind Pharma Ltd

Insights on Mankind Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.


    FII Holding Up

    Foreign Institutions have increased holdings from 2.61% to 4.18% in Jun 2023 quarter


    MF Holding Up

    Mutual Funds have increased holdings from 1.83% to 3.92% in Jun 2023 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    Promoters holdings remained unchanged at 76.50% of holdings in Jun 2023 quarter


    Retail Holding Down

    Retail Investor have decreased holdings from 18.25% to 14.68% in Jun 2023 quarter


    Price Dip

    In the last 1 month, MANKIND stock has moved down by -1.9%

Mankind Pharma Ltd Valuation

Mankind Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (41.33x)

May 24, 2023

Today (47.54x)

September 22, 2023

Industry (50.40x)

September 22, 2023

Highest (54.59x)

June 20, 2023


Mutual Fund Holdings

Funds Holdings
Axis Long Term Equity Fund Direct Plan Growth OptionAxis Long Term Equity Fund Direct Plan Growth Option1%
SBI Bluechip Fund Direct GrowthSBI Bluechip Fund Direct Growth0.67%
SBI Magnum Midcap Fund Direct GrowthSBI Magnum Midcap Fund Direct Growth1.61%
Nippon India Pharma Fund - Direct Plan - Growth PlanNippon India Pharma Fund - Direct Plan - Growth Plan3.19%
Motilal Oswal Long Term Equity Fund Direct Plan GrowthMotilal Oswal Long Term Equity Fund Direct Plan Growth5.05%

Mankind Pharma Ltd Shareholding Pattern

InvestorsHoldings %Prev. 3 periods3M change
Promoter Holdings
Foreign Institutions
Mutual Funds
Retail Investors

Technicals of Mankind Pharma Ltd

News & Events of Mankind Pharma Ltd

Frequently Asked Questions

Mankind Pharma Ltd (MANKIND) share price today is ₹1742.55

  • Today’s highest price of Mankind Pharma Ltd is ₹1759.9.
  • Today’s lowest price of Mankind Pharma Ltd is ₹1721.55.

Today’s traded volume of Mankind Pharma Ltd(MANKIND) is 78.96K.

Today’s market capitalisation of Mankind Pharma Ltd(MANKIND) is ₹70175.08Cr.

Mankind Pharma Ltd(MANKINDPrice
52 Week High
52 Week Low

Mankind Pharma Ltd(MANKIND) share price is ₹1742.55. It is down -10.59% from its 52 Week High price of ₹1949

Mankind Pharma Ltd(MANKIND) share price is ₹1742.55. It is up 40.30% from its 52 Week Low price of ₹1242

Mankind Pharma Ltd(MANKINDReturns
1 Day Returns
1 Month Returns
3 Month Returns
1 Year Returns